109 related articles for article (PubMed ID: 1968488)
21. Anti-NK cell treatment induces stable mixed chimerism in MHC-mismatched, T cell-depleted, nonmyeloablative bone marrow transplantation.
Cho SG; Shuto Y; Soda Y; Nakazaki Y; Izawa K; Uchimaru K; Takahashi S; Tani K; Tojo A; Asano S
Exp Hematol; 2004 Dec; 32(12):1246-54. PubMed ID: 15588949
[TBL] [Abstract][Full Text] [Related]
22. Studies of immunologic tolerance to host minor histocompatibility antigens following allogeneic bone marrow transplantation in mice.
Perreault C; Allard A; Brochu S; Poupart C; Fontaine P; Bélanger R; Gyger M
Bone Marrow Transplant; 1990 Aug; 6(2):127-35. PubMed ID: 2145050
[TBL] [Abstract][Full Text] [Related]
23. The effect of the spleen on compartmental levels and distribution of donor progenitor cells after syngeneic and allogeneic bone marrow transplants.
Shatry AM; Jones M; Levy RB
Stem Cells Dev; 2004 Feb; 13(1):51-62. PubMed ID: 15068693
[TBL] [Abstract][Full Text] [Related]
24. Rapamycin and T cell costimulatory blockade as post-transplant treatment promote fully MHC-mismatched allogeneic bone marrow engraftment under irradiation-free conditioning therapy.
Wu T; Sozen H; Luo B; Heuss N; Kalscheuer H; Lan P; Sutherland DE; Hering BJ; Guo Z
Bone Marrow Transplant; 2002 Jun; 29(12):949-56. PubMed ID: 12098061
[TBL] [Abstract][Full Text] [Related]
25. Addition of cyclophosphamide to T-cell depletion-based nonmyeloablative conditioning allows donor T-cell engraftment and clonal deletion of alloreactive host T-cells after bone marrow transplantation.
Xu H; Chilton PM; Huang Y; Schanie CL; Yan J; Ildstad ST
Transplantation; 2007 Apr; 83(7):954-63. PubMed ID: 17460568
[TBL] [Abstract][Full Text] [Related]
26. Alloresistance to K locus class I-mismatched bone marrow engraftment is mediated entirely by CD4+ and CD8+ T cells.
Hayashi H; LeGuern C; Sachs DH; Sykes M
Bone Marrow Transplant; 1996 Aug; 18(2):285-92. PubMed ID: 8864436
[TBL] [Abstract][Full Text] [Related]
27. Facilitation of parental-strain marrow engraftment by T cells of neonatally-tolerant mice.
Davenport C; George T; Devora GA; Morris MA; Gordon BE; Kumar V; Bennett M
Biol Blood Marrow Transplant; 1997 Dec; 3(6):294-303. PubMed ID: 9502296
[TBL] [Abstract][Full Text] [Related]
28. Durable mixed allogeneic chimerism and tolerance by a nonlethal radiation-based cytoreductive approach.
Colson YL; Li H; Boggs SS; Patrene KD; Johnson PC; Ildstad ST
J Immunol; 1996 Oct; 157(7):2820-9. PubMed ID: 8816385
[TBL] [Abstract][Full Text] [Related]
29. A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers.
Colson YL; Wren SM; Schuchert MJ; Patrene KD; Johnson PC; Boggs SS; Ildstad ST
J Immunol; 1995 Nov; 155(9):4179-88. PubMed ID: 7594573
[TBL] [Abstract][Full Text] [Related]
30. Two subpopulations of stem cells for T cell lineage.
Katsura Y; Amagai T; Kina T; Sado T; Nishikawa S
J Immunol; 1985 Nov; 135(5):3021-7. PubMed ID: 3900201
[TBL] [Abstract][Full Text] [Related]
31. The effect of natural killer cells on the development of syngeneic hematopoietic progenitors.
Holmberg LA; Miller BA; Ault KA
J Immunol; 1984 Dec; 133(6):2933-9. PubMed ID: 6436368
[TBL] [Abstract][Full Text] [Related]
32. Donor T cell and host NK depletion improve the therapeutic efficacy of allogeneic bone marrow cell reconstitution in the nonmyeloablatively conditioned tumor-bearing host.
Hummel S; Wilms D; Vitacolonna M; Zöller M
J Leukoc Biol; 2002 Nov; 72(5):898-912. PubMed ID: 12429711
[TBL] [Abstract][Full Text] [Related]
33. Stem cell transplantation in the normal nonmyeloablated host: relationship between cell dose, schedule, and engraftment.
Rao SS; Peters SO; Crittenden RB; Stewart FM; Ramshaw HS; Quesenberry PJ
Exp Hematol; 1997 Feb; 25(2):114-21. PubMed ID: 9015211
[TBL] [Abstract][Full Text] [Related]
34. Anti-asialo GM1 antiserum treatment of lethally irradiated recipients before bone marrow transplantation: evidence that recipient natural killer depletion enhances survival, engraftment, and hematopoietic recovery.
Tiberghien P; Longo DL; Wine JW; Alvord WG; Reynolds CW
Blood; 1990 Oct; 76(7):1419-30. PubMed ID: 2207317
[TBL] [Abstract][Full Text] [Related]
35. Natural suppressor cells in spleens of irradiated, bone marrow-reconstituted mice and normal bone marrow: lack of Sca-1 expression and enrichment by depletion of Mac1-positive cells.
Sykes M; Sharabi Y; Sachs DH
Cell Immunol; 1990 May; 127(2):260-74. PubMed ID: 1970279
[TBL] [Abstract][Full Text] [Related]
36. Neonatal tolerance induction in the thymus to MHC-class II-associated antigens. III. Significance of hemopoietic stem cells for induction and maintenance of Mls tolerance by continuous supply of tolerance-inducing nonlymphocytes.
Hosono M; Hosokawa T; Kina T; Katsura Y
Cell Immunol; 1987 Aug; 108(1):162-74. PubMed ID: 2886228
[TBL] [Abstract][Full Text] [Related]
37. Natural suppressor (NS) cells, neonatal tolerance, and total lymphoid irradiation: exploring obscure relationships.
Strober S
Annu Rev Immunol; 1984; 2():219-37. PubMed ID: 6152690
[TBL] [Abstract][Full Text] [Related]
38. Acute rejection of allogeneic hemopoietic progenitors by genetically resistant mice.
Shimamura K; Kaminsky SG; Nakamura I
Eur J Immunol; 1989 Jul; 19(7):1165-70. PubMed ID: 2569400
[TBL] [Abstract][Full Text] [Related]
39. Separation of mouse spleen haematopoietic cell fractions for transplantation purposes in lethally irradiated mice.
Fiala J; Viktora L; Fricová V; Hrubá A; Pristoupil TI
Physiol Bohemoslov; 1975; 24(3):275-81. PubMed ID: 238253
[TBL] [Abstract][Full Text] [Related]
40. Delayed activation of quiescent donor hematopoietic stem cells in the host marrow cavity by anti-host monoclonal antibody.
Sadelain MW; Wegmann TG
Blood; 1989 Nov; 74(7):2325-9. PubMed ID: 2804367
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
